Truncation of tau at Aps421 (tauD421) has been identified in AD brain, especially in NFTs, and it is believed that this truncation may enhance the aggregation of tau into filaments (Abraha et al., 2000; Gamblin et al., 2003). The gene discussed is MAPT; the disease is Alzheimer disease.